ADAM9 and central nervous system cancer: More importantly, despite the significant association between ADAM9 expression and disease-free survival (Supplementary Figure 2B), the high expression of ADAM9 was not significantly associated with overall poorer prognosis in patients diagnosed with glioma (Supplementary Figure 2A).